Now showing items 1-6 of 6

    • Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil 

      Luz, Paula M.; Morris, Bethany L.; Grinsztejn, Beatriz; Freedberg, Kenneth A.; Veloso, Valdilea G.; Walensky, Rochelle P.; Losina, Elena; Nakamura, Yoriko M.; Girouard, Michael P.; Sax, Paul E.; Struchiner, Claudio J.; Paltiel, A. David (JAIDS Journal of Acquired Immune Deficiency Syndromes, 2014)
      Objective: HIV genotype-resistance testing can help identify more effective antiretroviral treatment (ART) regimens for patients, substantially increasing the likelihood of viral suppression and immune recovery. We sought ...
    • Farmácia Popular Program: changes in geographic accessibility of medicines during ten years of a medicine subsidy policy in Brazil 

      Emmerick, Isabel Cristina Martins; do Nascimento, José Miguel; Pereira, Marco Aurélio; Luiza, Vera Lucia; Ross-Degnan, Dennis (BioMed Central, 2015)
      Objectives: The Brazilian constitution guarantees the right to health, including access to medicines. In May 2004, Brazil’s government announced the “Farmácia Popular” Program (FPP) as a new mechanism to improve the Brazilian ...
    • Prevalence of Depression and Depression Care for Populations Registered in Primary Care in Two Remote Cities in the Brazilian Amazon 

      Ribeiro dos Santos, Edinilza; Huang, Hsiang; Menezes, Paulo Rossi; Scazufca, Marcia (Public Library of Science, 2016)
      Background: The prevalence of depression has been widely studied in high-income countries and in large cities of low-income countries; however, little is known about the prevalence and treatment gap of depression in remote ...
    • Survival benefits of antiretroviral therapy in Brazil: a model-based analysis 

      Luz, Paula M; Girouard, Michael P; Grinsztejn, Beatriz; Freedberg, Kenneth A; Veloso, Valdilea G; Losina, Elena; Struchiner, Claudio J; MacLean, Rachel L; Parker, Robert A; Paltiel, A David; Walensky, Rochelle P (International AIDS Society, 2016)
      Objective: In Brazil, universal provision of antiretroviral therapy (ART) has been guaranteed free of charge to eligible HIV-positive patients since December 1996. We sought to quantify the survival benefits of ART ...
    • Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand 

      Lu, Christine Y; Emmerick, Isabel Cristina M; Stephens, Peter; Ross-Degnan, Dennis; Wagner, Anita K (BioMed Central, 2015)
      Objectives: New antidiabetic medications such as insulin analogues and thiazolidinediones have been introduced over the last decade. This study compares the uptake of new agents in three emerging pharmaceutical markets: ...
    • Zika Virus: Medical Countermeasure Development Challenges 

      Malone, Robert W.; Homan, Jane; Callahan, Michael V.; Glasspool-Malone, Jill; Damodaran, Lambodhar; Schneider, Adriano De Bernardi; Zimler, Rebecca; Talton, James; Cobb, Ronald R.; Ruzic, Ivan; Smith-Gagen, Julie; Janies, Daniel; Wilson, James (Public Library of Science, 2016)
      Introduction: Reports of high rates of primary microcephaly and Guillain–Barré syndrome associated with Zika virus infection in French Polynesia and Brazil have raised concerns that the virus circulating in these regions ...